Naghibi Khosrou, Rahimi Mojtaba, Mashayekhi Zahra
Department of Anesthesia and Intensive Care, Alzahra University Hospital, Isfahan, Iran.
Anesthesiology and Critical Care Research Center, Department of Anesthesiology and Intensive Care, Isfahan University of Medical Sciences, Isfahan, Iran.
Adv Biomed Res. 2017 May 29;6:60. doi: 10.4103/2277-9175.207147. eCollection 2017.
In this randomized, double-blinded case-control study, we investigated the intravenous effects of ephedrine or phenylephrine on prevention of post-spinal hypotension in elective lower abdominal surgery under spinal anesthesia.
One hundred and thirty-five patients, American Society of Anesthesiologists physical status I or II candidate for elective lower abdominal surgery under spinal anesthesia were randomized to three groups (45 each). According to their allocated group, patients received either ephedrine 2.5 mg (E group), phenylephrine (P group) 25 mic as vasopressor or the same volume of saline normal as placebo (S group) immediately after the spinal anesthesia. hemodynamic parameters, and complications were recorded.
Patients' demographics were similar in all the groups. The mean systolic blood pressure (SBP), diastolic blood pressure (DBP), and MAP and also heart rate were similar over time for groups E and P ( > 0.05). The incidence of reactive hypertension was more in group E than group P and placebo ( < 0.05). The incidence of nausea and vomiting were significantly lower in groups E and P in comparison with placebo ( < 0.05).
Although the mean fall of SBP and DBP were significantly less in groups E and P compared with placebo but we did not find significant differences in prophylactic use of ephedrine or phenylephrine for prevention of post-spinal hypotension in elective lower abdominal surgery. Vasopressors infusion have added benefit of lower incidence of nausea and vomiting.
在这项随机、双盲病例对照研究中,我们调查了麻黄碱或去氧肾上腺素静脉注射对预防脊髓麻醉下择期下腹部手术术后脊髓性低血压的效果。
135例美国麻醉医师协会身体状况为I或II级、拟行脊髓麻醉下择期下腹部手术的患者被随机分为三组(每组45例)。根据分组情况,患者在脊髓麻醉后立即接受2.5毫克麻黄碱(E组)、25微克去氧肾上腺素(P组)作为血管升压药或相同体积的生理盐水作为安慰剂(S组)。记录血流动力学参数和并发症。
所有组患者的人口统计学特征相似。E组和P组的平均收缩压(SBP)、舒张压(DBP)、平均动脉压(MAP)以及心率随时间变化相似(P>0.05)。E组反应性高血压的发生率高于P组和安慰剂组(P<0.05)。与安慰剂组相比,E组和P组恶心呕吐的发生率显著降低(P<0.05)。
虽然与安慰剂组相比,E组和P组SBP和DBP的平均下降幅度显著较小,但我们发现在择期下腹部手术中预防性使用麻黄碱或去氧肾上腺素预防脊髓性低血压方面没有显著差异。输注血管升压药还有降低恶心呕吐发生率的额外益处。